FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056351612> ?p ?o ?g. }

• W2056351612 endingPage "402" @default.
• W2056351612 startingPage "397" @default.
• W2056351612 abstract "PurposeWe previously developed a novel antitumor prodrug that has a 2-oxopropyl substituent at the N(1) position of 5-fluorouracil (5-FU) and releases 5-FU via one-electron reduction on hypoxic irradiation. Although the compound was effective in vivo, its activity against murine tumors was not high enough to warrant clinical studies. Therefore, we developed a similar family of radiation-activated prodrugs of 5-fluoro-2′-deoxyuridine (FdUrd), which is generally more potent than 5-FU, and investigated their radiation chemical reactivity and in vitro and in vivo effects.Methods and materialsCompounds bearing various 2-oxoalkyl substituents at the N(3) position of FdUrd were synthesized and investigated. After aerobic or hypoxic irradiation to the prodrugs dissolved in water or culture medium, release of FdUrd was measured using high-performance liquid chromatography. To investigate in vitro cytotoxicity, SCCVII and EMT6 cells in culture were irradiated in the presence of the prodrug under aerobic or hypoxic conditions, and then kept with the compound for 24 h. Cell survival was then measured using a colony assay. To investigate in vivo effects, the drug was injected intraperitoneally at a dose of 100 or 300 mg/kg into Balb/c mice bearing EMT6 tumors 30 min before irradiation. The tumor growth delay-time was then assessed.ResultsIn vitro, the prodrugs released FdUrd at G-values (molar numbers of molecules produced by 1 J of radiation energy) of 1.6–2.0 × 10−7 mol/J after hypoxic irradiation. The G-values for FdUrd release with hypoxic irradiation were about 100-fold greater than those with aerobic irradiation. Among the prodrugs tested, OFU106 bearing a 2-oxocyclopentyl substituent released the highest amount of FdUrd in the culture medium, and it was subjected to further in vitro and in vivo assays. Although OFU106 administered alone showed no cytotoxicity up to a concentration of 0.2 mM, it produced an enhanced cytotoxic effect when administered before hypoxic irradiation and kept with the cells for 24 h. The enhancement ratios calculated at the surviving fraction of 1% were 1.35–1.4 at 0.04 mM and 1.45–1.5 at 0.2 mM. In vivo, however, administration of OFU106 (100 or 300 mg/kg) before 20 Gy of irradiation did not produce marked growth delays compared with 20 Gy of radiation alone.ConclusionOn hypoxic irradiation in vitro, the prodrugs of FdUrd were activated as efficiently as were the prodrugs of 5-FU, but marked in vivo effects could not be detected. This strategy of prodrug design should be used in further development of radiation-activated prodrugs of more potent anticancer agents." @default.
• W2056351612 created "2016-06-24" @default.
• W2056351612 creator A5014787967 @default.
• W2056351612 creator A5050893006 @default.
• W2056351612 creator A5071240286 @default.
• W2056351612 creator A5075706182 @default.
• W2056351612 creator A5089437525 @default.
• W2056351612 date "2004-02-01" @default.
• W2056351612 modified "2023-10-15" @default.
• W2056351612 title "In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2′-deoxyuridine activated by hypoxic irradiation" @default.
• W2056351612 cites W1541964738 @default.
• W2056351612 cites W1784479792 @default.
• W2056351612 cites W1930978022 @default.
• W2056351612 cites W1944220675 @default.
• W2056351612 cites W1967318643 @default.
• W2056351612 cites W1970100282 @default.
• W2056351612 cites W1985049521 @default.
• W2056351612 cites W2003984058 @default.
• W2056351612 cites W2028894122 @default.
• W2056351612 cites W2032093753 @default.
• W2056351612 cites W2045943543 @default.
• W2056351612 cites W2053296503 @default.
• W2056351612 cites W2059232606 @default.
• W2056351612 cites W2059568689 @default.
• W2056351612 cites W2074959436 @default.
• W2056351612 cites W2082497822 @default.
• W2056351612 cites W2086878786 @default.
• W2056351612 cites W2093716126 @default.
• W2056351612 cites W2136759492 @default.
• W2056351612 cites W2136817236 @default.
• W2056351612 cites W2151900394 @default.
• W2056351612 cites W2155053061 @default.
• W2056351612 cites W2166828354 @default.
• W2056351612 doi "https://doi.org/10.1016/j.ijrobp.2003.09.048" @default.
• W2056351612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14751508" @default.
• W2056351612 hasPublicationYear "2004" @default.
• W2056351612 type Work @default.
• W2056351612 sameAs 2056351612 @default.
• W2056351612 citedByCount "25" @default.
• W2056351612 countsByYear W20563516122012 @default.
• W2056351612 countsByYear W20563516122015 @default.
• W2056351612 countsByYear W20563516122016 @default.
• W2056351612 crossrefType "journal-article" @default.
• W2056351612 hasAuthorship W2056351612A5014787967 @default.
• W2056351612 hasAuthorship W2056351612A5050893006 @default.
• W2056351612 hasAuthorship W2056351612A5071240286 @default.
• W2056351612 hasAuthorship W2056351612A5075706182 @default.
• W2056351612 hasAuthorship W2056351612A5089437525 @default.
• W2056351612 hasBestOaLocation W20563516121 @default.
• W2056351612 hasConcept C108215921 @default.
• W2056351612 hasConcept C150903083 @default.
• W2056351612 hasConcept C185592680 @default.
• W2056351612 hasConcept C202751555 @default.
• W2056351612 hasConcept C207001950 @default.
• W2056351612 hasConcept C2777111502 @default.
• W2056351612 hasConcept C552990157 @default.
• W2056351612 hasConcept C55493867 @default.
• W2056351612 hasConcept C71924100 @default.
• W2056351612 hasConcept C86803240 @default.
• W2056351612 hasConcept C98274493 @default.
• W2056351612 hasConceptScore W2056351612C108215921 @default.
• W2056351612 hasConceptScore W2056351612C150903083 @default.
• W2056351612 hasConceptScore W2056351612C185592680 @default.
• W2056351612 hasConceptScore W2056351612C202751555 @default.
• W2056351612 hasConceptScore W2056351612C207001950 @default.
• W2056351612 hasConceptScore W2056351612C2777111502 @default.
• W2056351612 hasConceptScore W2056351612C552990157 @default.
• W2056351612 hasConceptScore W2056351612C55493867 @default.
• W2056351612 hasConceptScore W2056351612C71924100 @default.
• W2056351612 hasConceptScore W2056351612C86803240 @default.
• W2056351612 hasConceptScore W2056351612C98274493 @default.
• W2056351612 hasFunder F4320320912 @default.
• W2056351612 hasIssue "2" @default.
• W2056351612 hasLocation W20563516121 @default.
• W2056351612 hasLocation W20563516122 @default.
• W2056351612 hasOpenAccess W2056351612 @default.
• W2056351612 hasPrimaryLocation W20563516121 @default.
• W2056351612 hasRelatedWork W1566729005 @default.
• W2056351612 hasRelatedWork W1700716001 @default.
• W2056351612 hasRelatedWork W2013908504 @default.
• W2056351612 hasRelatedWork W2054843986 @default.
• W2056351612 hasRelatedWork W2116210813 @default.
• W2056351612 hasRelatedWork W2138350991 @default.
• W2056351612 hasRelatedWork W2409285845 @default.
• W2056351612 hasRelatedWork W2434195791 @default.
• W2056351612 hasRelatedWork W2440701365 @default.
• W2056351612 hasRelatedWork W3015376786 @default.
• W2056351612 hasVolume "58" @default.
• W2056351612 isParatext "false" @default.
• W2056351612 isRetracted "false" @default.
• W2056351612 magId "2056351612" @default.
• W2056351612 workType "article" @default.